vs
Side-by-side financial comparison of Sprout Social, Inc. (SPT) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $92.9M, roughly 1.3× Vericel Corp). On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 12.9%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $9.9M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 11.8%).
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
SPT vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.9M | $92.9M |
| Net Profit | — | $23.2M |
| Gross Margin | 77.6% | 78.7% |
| Operating Margin | -9.0% | 24.1% |
| Net Margin | — | 25.0% |
| Revenue YoY | 12.9% | 23.3% |
| Net Profit YoY | — | 17.3% |
| EPS (diluted) | $-0.18 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.9M | $92.9M | ||
| Q3 25 | $115.6M | $67.5M | ||
| Q2 25 | $111.8M | $63.2M | ||
| Q1 25 | $109.3M | $52.6M | ||
| Q4 24 | $107.1M | $75.4M | ||
| Q3 24 | $102.6M | $57.9M | ||
| Q2 24 | $99.4M | $52.7M | ||
| Q1 24 | $96.8M | $51.3M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $-9.4M | $5.1M | ||
| Q2 25 | $-12.0M | $-553.0K | ||
| Q1 25 | $-11.2M | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $-17.1M | $-901.0K | ||
| Q2 24 | $-16.9M | $-4.7M | ||
| Q1 24 | $-13.6M | $-3.9M |
| Q4 25 | 77.6% | 78.7% | ||
| Q3 25 | 77.7% | 73.5% | ||
| Q2 25 | 77.7% | 73.7% | ||
| Q1 25 | 77.3% | 69.0% | ||
| Q4 24 | 78.1% | 77.6% | ||
| Q3 24 | 77.4% | 71.9% | ||
| Q2 24 | 77.5% | 69.5% | ||
| Q1 24 | 76.8% | 68.9% |
| Q4 25 | -9.0% | 24.1% | ||
| Q3 25 | -7.9% | 5.1% | ||
| Q2 25 | -11.0% | -3.2% | ||
| Q1 25 | -10.2% | -24.3% | ||
| Q4 24 | -12.8% | 24.5% | ||
| Q3 24 | -16.4% | -4.3% | ||
| Q2 24 | -16.6% | -11.5% | ||
| Q1 24 | -13.7% | -10.7% |
| Q4 25 | — | 25.0% | ||
| Q3 25 | -8.1% | 7.5% | ||
| Q2 25 | -10.7% | -0.9% | ||
| Q1 25 | -10.3% | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | -16.6% | -1.6% | ||
| Q2 24 | -17.0% | -8.9% | ||
| Q1 24 | -14.0% | -7.5% |
| Q4 25 | $-0.18 | $0.46 | ||
| Q3 25 | $-0.16 | $0.10 | ||
| Q2 25 | $-0.21 | $-0.01 | ||
| Q1 25 | $-0.19 | $-0.23 | ||
| Q4 24 | $-0.25 | $0.40 | ||
| Q3 24 | $-0.30 | $-0.02 | ||
| Q2 24 | $-0.30 | $-0.10 | ||
| Q1 24 | $-0.24 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $95.3M | $137.5M |
| Total DebtLower is stronger | $40.0M | — |
| Stockholders' EquityBook value | $203.4M | $354.6M |
| Total Assets | $523.1M | $488.0M |
| Debt / EquityLower = less leverage | 0.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $137.5M | ||
| Q3 25 | $90.6M | $135.4M | ||
| Q2 25 | $101.5M | $116.9M | ||
| Q1 25 | $100.9M | $112.9M | ||
| Q4 24 | $86.4M | $116.2M | ||
| Q3 24 | $82.9M | $101.7M | ||
| Q2 24 | $80.9M | $102.5M | ||
| Q1 24 | $69.2M | $110.6M |
| Q4 25 | $40.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $25.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $203.4M | $354.6M | ||
| Q3 25 | $194.1M | $321.9M | ||
| Q2 25 | $184.6M | $306.8M | ||
| Q1 25 | $175.3M | $295.5M | ||
| Q4 24 | $166.6M | $292.0M | ||
| Q3 24 | $158.1M | $257.5M | ||
| Q2 24 | $152.1M | $243.0M | ||
| Q1 24 | $147.3M | $233.9M |
| Q4 25 | $523.1M | $488.0M | ||
| Q3 25 | $481.4M | $453.3M | ||
| Q2 25 | $422.9M | $435.6M | ||
| Q1 25 | $424.7M | $424.6M | ||
| Q4 24 | $428.3M | $432.7M | ||
| Q3 24 | $388.8M | $390.4M | ||
| Q2 24 | $393.6M | $376.8M | ||
| Q1 24 | $389.9M | $356.7M |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.9M | $15.0M |
| Free Cash FlowOCF − Capex | $9.9M | $12.8M |
| FCF MarginFCF / Revenue | 8.2% | 13.8% |
| Capex IntensityCapex / Revenue | 0.9% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $39.3M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.9M | $15.0M | ||
| Q3 25 | $9.3M | $22.1M | ||
| Q2 25 | $5.1M | $8.2M | ||
| Q1 25 | $18.1M | $6.6M | ||
| Q4 24 | $4.1M | $22.2M | ||
| Q3 24 | $9.0M | $10.2M | ||
| Q2 24 | $2.1M | $18.5M | ||
| Q1 24 | $11.2M | $7.2M |
| Q4 25 | $9.9M | $12.8M | ||
| Q3 25 | $8.5M | $19.5M | ||
| Q2 25 | $4.2M | $81.0K | ||
| Q1 25 | $16.7M | $-7.6M | ||
| Q4 24 | $3.3M | $8.5M | ||
| Q3 24 | $8.5M | $-9.2M | ||
| Q2 24 | $1.6M | $1.8M | ||
| Q1 24 | $10.1M | $-6.8M |
| Q4 25 | 8.2% | 13.8% | ||
| Q3 25 | 7.4% | 28.8% | ||
| Q2 25 | 3.7% | 0.1% | ||
| Q1 25 | 15.3% | -14.5% | ||
| Q4 24 | 3.0% | 11.2% | ||
| Q3 24 | 8.3% | -15.9% | ||
| Q2 24 | 1.6% | 3.4% | ||
| Q1 24 | 10.4% | -13.3% |
| Q4 25 | 0.9% | 2.4% | ||
| Q3 25 | 0.7% | 3.9% | ||
| Q2 25 | 0.8% | 12.9% | ||
| Q1 25 | 1.2% | 27.0% | ||
| Q4 24 | 0.8% | 18.3% | ||
| Q3 24 | 0.5% | 33.5% | ||
| Q2 24 | 0.5% | 31.8% | ||
| Q1 24 | 1.1% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SPT
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
